Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology
Disease Category: Myelodysplastic Syndromes (MDS)
Location: United States, ND

Clinical Trial Details

Overview

Research Study Summary

Myelodysplastic Syndrome (MDS)

Purpose

To evaluate the efficacy of romiplostim for the treatment of thrombocytopenia in subjects with MDS

Patient Inclusion Criteria:

  • Diagnosis of MDS, 18+ years of age, adequate liver function, written informed consent

Patient Exclusion Criteria:

  • Have ever received any disease-modifying treatment MDS, Previously diagnosed with intermediate-2 or high risk MDS using the IPSS, prior history of leukemia, aplastic anemia, prior history of hematopoietic stem cell transplantation, active or uncontrolled infections, unstable angina, pregnant or breast feeding

To Learn more
Phase

2

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 163102

Date Last Changed: July 24, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.